Quarter Financials
La Jolla Pharmaceutical Company (LJPC)
$6.22
0.00 (-%)
Income Statement
Balance Sheet
Cash Flow
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
Net Income | 2 | 0 | 4 | -2 | 4 | 14 | -3 | -12 |
Dividend Paid | - | - | - | - | - | - | - | - |
Retained Earnings | -1,055 | -1,057 | -1,057 | -1,061 | -1,059 | -1,062 | -1,077 | -1,073 |
---|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
Capital Expenditure | - | - | - | - | - | - | - | - |
Net PPE | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 |
---|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
New Purchases | - | - | - | - | - | - | - | 0 |
Intangible and Goodwill | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
---|